Irhythm Technologies Inc. (IRTC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Irhythm Technologies Inc. (IRTC:NASDAQ), powered by AI.

Current Price
$113.65
P/E Ratio
-81.6
Market Cap
3.6B
Sector
Healthcare
What is the Irhythm Technologies Inc. stock price forecast?

Irhythm Technologies Inc. is currently trading at $113.65. View real-time AI analysis on Alpha Lenz.

What is Irhythm Technologies Inc. insider trading activity?

View the latest insider trading data for Irhythm Technologies Inc. on Alpha Lenz.

What is Irhythm Technologies Inc.'s P/E ratio?

Irhythm Technologies Inc.'s P/E ratio is -81.6.

Irhythm Technologies Inc.

NASDAQ · IRTC
$113.65+0.98(+0.87%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Irhythm Technologies Inc.'s future dividend policy...
Alpha Chat Insight

Irhythm Technologies Inc. trades at a P/E of -81.6 (undervalued) with modest ROE of -36.6%. 3Y revenue CAGR of 22.1% highlights clear growth momentum.

Ask for details

Company Overview

Irhythm Technologies Inc. is a healthcare technology company that specializes in the development of remote monitoring solutions for cardiac arrhythmias. Its primary product, the Zio service, is a comprehensive platform integrating wearable biosensors and cloud-based data analytics to facilitate the early detection and diagnosis of irregular heart rhythms. By harnessing advanced biosensing technology, Irhythm provides continuous, real-time heart monitoring, enabling healthcare providers to make more informed decisions about patient care. The company operates at the critical intersection of healthcare and technology, playing an influential role in the medical devices sector through its innovative approach to cardiac monitoring. By improving the accuracy and efficiency of arrhythmia detection, Irhythm Technologies Inc. contributes significantly to enhanced clinical outcomes and helps reduce the burdens on healthcare systems. Launched with a mission to elevate cardiovascular care, Irhythm Technologies has gained market significance by addressing the unmet needs of both patients and healthcare providers. The company's solutions are pivotal in transitioning cardiac care from traditional clinical settings to personalized home environments, thereby expanding the accessibility and effectiveness of cardiac health management.

CEOMr. Quentin S. Blackford
SectorHealthcare
IndustryMedical Devices
Employees2,000

Company Statistics

FY 2025

Profile

$3.64BMarket Cap
$747.14MRevenue
0.00Shares Out
2,000Employees

Margins

70.57%Gross
0.07%EBITDA
-7.09%Operating
-5.84%Pre-Tax
-5.96%Net

Valuation

-81.64P/E
23.81P/B
4.87EV/Sales
8382.20EV/EBITDA
105.36P/FCF

Growth (CAGR)

22.05%Rev 3Yr
23.02%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-4.57%ROA
-36.57%ROE
-3.12%ROIC

Financial Health

$236.01MCash & Cash Equivalents
$631.28MNet Debt
567.80%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Irhythm Technologies Inc. (ticker: IRTC) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 2,000 employees. Market cap is $3.6B.

The current price is $113.65 with a P/E ratio of -81.64x and P/B of 23.81x.

ROE is -36.57% and operating margin is -7.09%. Annual revenue is $747M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Irhythm Technologies Inc. (IRTC) Stock Forecast 2026 $113.65 — Price, Financials & Analyst Targets | Alpha Lenz